The continuous manufacturing market is estimated to be worth around USD 2 billion in 2030
Recent advances in the manufacturing technologies haveprompted pharmaceutical companies to consider shifting from the traditionalmulti-step, batch manufacturing processes to faster, and relatively moreefficient continuous manufacturing
Roots Analysis is pleased to announce the publication of its recent study,titled, “ContinuousManufacturing Market (Small Molecules and Biologics), 2020 – 2030.”
The report features an extensive study of thecurrent market landscape and future opportunities for companies withcapabilities in continuous manufacturing (both innovator companies within-house expertise and contract manufacturers). It features an in-depthanalysis, highlighting the capabilities of various stakeholders engaged in thisdomain. In addition to other elements, the study includes:
§ A detailed assessment of the overall landscapeof companies with capabilities for continuous manufacturing
§ Elaborate profiles of some of the key contractmanufacturers active in the pharmaceutical and biopharmaceutical continuousmanufacturing market
§ An analysis of the various partnerships related tocontinuous manufacturing, which have been established since 2013
§ An analysis of the expansions related to continuousmanufacturing, which have been established since 2013
§ An estimate of the global, continuous manufacturingcapacity, based on the capacities of various industry stakeholders (as availableon their respective company websites).
§ A study of the various grants that have been awarded toresearch institutes engaged in projects related to continuous manufacturing,between 2014 and 2019
§ An in-depth analysis of the various patents that have beenfiled / granted related to continuous manufacturing till 2019
§ Initiatives taken by the leading pharmaceutical companies(in terms of revenues), covering both partnered as well as in-house projects.
§ A review of the companies offering modular facilities /modular cleanrooms
§ A case study of the companies offering technologies /equipment
§ A case study on the roadmap for the adoption of continuousmanufacturing technique
§ A detailed marketforecast, featuring analysis of the current and projected future opportunityacross key market segments (listed below)
§ Purposeof Manufacturing
§ In-House
§ Contract service
§ Scaleof Operation
§ Commercial
§ Preclinical /Clinical
§ Typeof Continuous Manufacturing related Service
§ APIManufacturing
§ EndProduct manufacturing
§ Typeof Drug Molecule
§ Biologic
§ Small Molecule
§ Typeof dosage form
§ Solid
§ Liquid
§ KeyGeographical Regions
§ North America
§ Europe
§ Asia Pacific
§ Transcripts of interviews held with the following seniorlevel representatives of stakeholder companies
§ Andrea Adamo, Founderand Chief Executive Officer, Zaiput Flow technologies
§ Bayan Takizawa, Co-Founderand Chief Business Officer, CONTINUUS Pharmaceuticals
§ Nick Thomson, SeniorDirector Chemical Research and Development, Pfizer
§ Himanshu Gadgil, Directorand Chief Scientific Officer, Enzene Biosciences
§ Eric Fang, ChiefScientific Officer, Snapdragon Chemistry)
§ Ian Houson, TechnicalProject Manager, Continuous Manufacturing and Crystallization, University ofStrathclyde
Keycompanies covered in the report
§ AbbVie ContractManufacturing
§ Ajinomoto Bio-PharmaServices
§ Almac
§ Boehringer IngelheimBioXcellence
§ Cambrex
§ CordonPharma
§ Hovione
§ Kaneka
§ Lonza
§ Patheon
§ SK biotek
§ WuXi AppTec
Formore information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html
Other Offerings
1. PharmaceuticalContract Manufacturing Market (2nd Edition),2018-2028
2. BiopharmaContract Manufacturing Market (3rd Edition), 2019 - 2030
3. ChinaPharmaceutical Contract Manufacturing Services Market,2020-2030
4. ChinaBiopharmaceutical Contract Manufacturing Market,2020 - 2030
About Roots Analysis
Roots Analysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
